
A visionary diagnostic company dedicated to transforming the landscape of cancer care. 'Breaking Barriers to Precision Oncology' reflects our commitment to revolutionizing cancer diagnosis and treatment.

BioView develops and markets innovative automated cell imaging and analysis solutions for cytology, cytogenetics, and pathology laboratories. Their advanced platforms enhance cancer and genetic diagnostics by automating complex tasks with high accuracy, efficiency, and AI-driven analysis, supporting faster and standardized lab workflows

HLB Panagene is a South Korean leader in molecular diagnostics, specializing in peptide nucleic acid (PNA) technology for highly sensitive and specific gene diagnostic kits. Their products include liquid biopsy and tissue biopsy tests for various cancers and infectious diseases, supporting precision medicine and rapid detection with advanced AI integration.

Predicine is a global molecular insights company advancing precision medicine in oncology and infectious diseases. They develop liquid biopsy technology analyzing cell-free DNA and RNA for non-invasive cancer diagnostics, treatment monitoring, and minimal residual disease detection.

Sniper Medical Technologies is a leading molecular diagnostics company specializing in fully automated digital PCR platforms. Their patented VibroJect® droplet generation technology offers high sensitivity, precision, and efficiency for detecting multiple targets simultaneously. Certified by FDA, CE, and NMPA, Sniper’s systems simplify workflows while delivering reliable, rapid results for precision medicine.
Bridgeway Healthcare Technology Limited
Unit 25, 8/F, Metro Centre I,, 32 Lam Hing Street, Kowloon Bay,, Hong Kong
Email: info@bridgewayhk.com
Copyright © 2025 Bridgeway Healthcare Technology Limited — All rights reserved